Physician profile
Daniel V Alexander
NPI 1184841470
$22,879.80
in general payments reported to CMS, 2019-2025
23 companies · $2,687 in 2025
The $2,687 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,236 · 2020: $326 · 2021: $2,304 · 2022: $3,057 · 2023: $6,775 · 2024: $6,494 · 2025: $2,687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,492 · Food and Beverage: $7,464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,492.07 |
| Food and Beverage | $7,463.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,389.20 | 2019-2025 | Aveir, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Medtronic, INC. | $9,277.94 | 2021-2025 | Diamondtemp Bidirectional Ablation Catheter, Evera Mri Xt Dr Surescan, Na |
| Boston Scientific Corporation | $1,440.76 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Farapulse, Watchman Access System |
| Biosense Webster, INC. | $732.25 | 2020-2025 | Carto 3, Nuvision Ice Catheter |
| Medtronic Vascular, INC. | $400.26 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $378.25 | 2021-2025 | Jardiance |
| Pfizer INC. | $200.41 | 2019-2025 | |
| Philips North America LLC | $166.18 | 2020-2025 | Extended Holter, (Ck4) Mcot |
| Impulse Dynamics (USA) INC. | $153.42 | 2021-2024 | Optimizer, Optimizer |
| Novartis Pharmaceuticals Corporation | $114.42 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.54 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $96.99 | 2019-2025 | Camzyos, Eliquis |
| Atricure, INC. | $79.40 | 2019-2023 | |
| Amgen INC. | $71.53 | 2019-2022 | |
| Cardiva Medical, INC. | $57.30 | 2024-2025 | Optowire, Cardiva Vascade Mvp Vvcs 6-12f |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $41.59 | 2019 | |
| Sanofi-Aventis U.S. LLC | $41.15 | 2023 | |
| Novo Nordisk INC | $37.91 | 2023-2024 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $34.55 | 2021-2022 | |
| Gilead Sciences, INC. | $22.26 | 2023 | |
| Esperion Therapeutics, INC. | $16.68 | 2022 | |
| Celonova Biosciences, INC. | $13.95 | 2019 | |
| Cvrx, INC. | $12.86 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.